載入...
Clinical drug development for dementia with Lewy bodies: past and present
INTRODUCTION: Dementia with Lewy bodies (DLB) is an under-researched area despite being the second most common type of degenerative dementia after Alzheimer’s disease. It is an area of unmet need with no approved symptomatic or disease-modifying therapies. The pharmacological management of DLB is co...
Na minha lista:
| 發表在: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823159/ https://ncbi.nlm.nih.gov/pubmed/31614096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543784.2019.1681398 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|